Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 19, 2026

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

Drug screening study using glioma stem-like cells.

Xing Feng1, Qin Zhou, Chong Liu

  • 1College of Medicine, Hunan Normal University, Changsha, Hunan 410006, PR China. fengxing01@hotmail.com

Molecular Medicine Reports
|August 28, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review of NEDDylation inhibition activity detection methods.

Bioorganic & medicinal chemistry·2020
Same author

Optimization of Process Parameters of Rhamnolipid Treatment of Oily Sludge Based on Response Surface Methodology.

ACS omega·2020
Same author

Safety and Long-term Scleral Biomechanical Stability of Rhesus Eyes after Scleral Cross-linking by Blue Light.

Current eye research·2020
Same author

Serum pentraxin 3 as a biomarker for prognosis of acute minor stroke due to large artery atherosclerosis.

Brain and behavior·2020
Same author

The roles of adenosine deaminase in autoimmune diseases.

Autoimmunity reviews·2020
Same author

The role of oxidative stress in association between disinfection by-products exposure and semen quality: A mediation analysis among men from an infertility clinic.

Chemosphere·2020
Same journal

Human parvovirus B19 VP1u‑induced osteoclastogenesis is enhanced by RANKL in RAW264.7 macrophage cells.

Molecular medicine reports·2026
Same journal

Proteolysis‑targeting chimeras in oral squamous cell carcinoma: Current evidence, translational challenges and future directions (Review).

Molecular medicine reports·2026
Same journal

Aspirin prevents postoperative peritoneal adhesions by inhibiting the TGF‑β1/Smad signaling pathway in rats.

Molecular medicine reports·2026
Same journal

Evolving role of biomarkers beyond prostate‑specific antigen in refining prostate cancer screening: From blood‑based tests to urinary and genetic markers (Review).

Molecular medicine reports·2026
Same journal

[Retracted] Anti‑tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC‑803 proliferation via phospho-extracellular signal‑regulated kinase‑, Src‑, c‑Jun N‑terminal kinase‑ and phosphoinositide 3--kinase‑associated pathways.

Molecular medicine reports·2026
Same journal

TREM2 in glioma: Reprogramming the immune microenvironment from mechanistic understanding to clinical translation (Review).

Molecular medicine reports·2026
See all related articles

Researchers identified six active drugs, including curcumin and luteolin, that impact glioma stem-like cells (GSLCs). These findings offer new avenues for studying and treating malignant glioma, a common brain tumor.

Area of Science:

  • Neuro-oncology
  • Cancer Stem Cell Biology

Background:

  • Glioma represents a significant portion of primary malignant brain tumors.
  • Understanding glioma stem-like cells (GSLCs) is crucial for developing effective treatments.

Purpose of the Study:

  • To establish a method for generating glioma stem-like cells (GSLCs).
  • To screen active drugs from 12 classes for their efficacy against GSLCs.
  • To identify potential therapeutic agents for human glioma.

Main Methods:

  • Glioma stem-like cells (GSLCs) were induced from U251 cells using serum-free suspension clone formation.
  • Drug screening was performed using MTT assays across 12 drug classes.
  • The effect of identified drugs on tumor ball formation was assessed.
Keywords:
glioma stem-like cellsglioma cellsMTT

More Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

Related Experiment Videos

Last Updated: May 19, 2026

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

Main Results:

  • Serum-free suspension clone formation successfully generated GSLCs with cancer stem cell characteristics.
  • Six active drugs were identified: curcumin, chrysin, apigenin, luteolin, casticin, and 8-bromo-7-methoxychrysin (BrMChR).
  • Curcumin, luteolin, casticin, and BrMChR significantly affected the number of tumor balls (P<0.05).

Conclusions:

  • The study successfully established a method for generating GSLCs.
  • Several natural compounds and a synthetic derivative show potential in targeting GSLCs.
  • These findings provide a foundation for further research into novel glioma therapies.